HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of melatonin on sleep quality and EEG features in childhood epilepsy: a possible non-conventional treatment.

AbstractBackground:
Sleep and epilepsy are characterized by a bidirectional relationship. Indeed, epilepsy predisposes to the development of sleep disorders, while sleep deprivation may exacerbate epilepsy. In addition, antiseizure medication can disrupt normal sleep architecture. Therefore, adequate sleep hygiene could lead to improvement in seizure control. The present study aimed to evaluate the effect of melatonin on seizure frequency, EEG tracing, and sleep in children with focal idiopathic epilepsy.
Methods:
This observation study evaluated the effect of 4 mg oral melatonin in ameliorating sleep-wake cycle, seizure frequency, and EEG features in children with focal idiopathic epilepsy of infancy. Twenty children were enrolled from September 2020 to August 2021. The study consisted of serial controls at enrollment (t0), at 3 months (t1), and at 6 months (t2) including neurological examination, questionnaire about sleep disturbances (CSHQ), and EEG.
Results:
A significant improvement in sleep quality and daytime sleepiness was observed after melatonin supplementation. Furthermore, we observed a noteworthy improvement in EEG tracing at t2 that exhibited a significant correlation with improvements in CSHQ scores.
Conclusion:
The studies conducted so far to evaluate the effect of melatonin in persons with epilepsy do not lead to definitive conclusions. Despite the small population sample and the study design, we report sleep and EEG improvement after melatonin administration in our cohort. Larger studies are needed to further study the neuroprotective and anticonvulsant properties of melatonin.
AuthorsGiovanni Battista Dell'Isola, Giorgia Tascini, Valerio Vinti, Eleonora Tulli, Gianluca Dini, Elisabetta Mencaroni, Pietro Ferrara, Giuseppe Di Cara, Pasquale Striano, Alberto Verrotti
JournalFrontiers in neurology (Front Neurol) Vol. 14 Pg. 1243917 ( 2023) ISSN: 1664-2295 [Print] Switzerland
PMID37780697 (Publication Type: Journal Article)
CopyrightCopyright © 2023 Dell'Isola, Tascini, Vinti, Tulli, Dini, Mencaroni, Ferrara, Di Cara, Striano and Verrotti.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: